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ABSTRACT

43

Background: Dietary nitrate is an important source of nitric oxide (NO), a molecule critical

44

for cardiovascular health. Nitrate is sequentially reduced to NO through an enterosalivary

45

nitrate-nitrite-NO pathway that involves the oral microbiome. This pathway is considered an

46

important adjunct pathway to the classical L-arginine-NO synthase pathway. The objective of

47

this study was to systematically assess the evidence for dietary nitrate intake and improved

48

cardiovascular health from both human and animal studies.

49

Methods: A systematic literature search was performed according to PRISMA guidelines

50

using key search terms in Medline and EMBASE databases and defined inclusion and

51

exclusion criteria.

52

Results: Thirty-seven articles were included on humans and fourteen articles on animals

53

from 12,541 screened references. Data on the effects of dietary nitrate on blood pressure,

54

endothelial function, ischaemic reperfusion injury, arterial stiffness, platelet function, and

55

cerebral blood flow in both human and animal models were identified. Beneficial effects of

56

nitrate on vascular health have predominantly been observed in healthy human populations

57

while effects in populations at risk of cardiovascular disease are less clear. Few studies have

58

investigated the long-term effects of dietary nitrate on cardiovascular disease clinical

59

endpoints. In animal studies, there is evidence that nitrate improves blood pressure and

60

endothelial function particularly in animal models with reduced NO bioavailability. Nitrate

61

dose seems to be a critical factor as there is evidence of cross-talk between the two pathways

62

of NO production.

63

Conclusion: Evidence for a beneficial effect in humans at risk of cardiovascular disease is

64

limited. Furthermore, there is a need to investigate the long-term effects of dietary nitrate on

65

cardiovascular disease clinical endpoints. Further animal studies are required to elucidate the

66

mechanisms behind the observed effects.
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Introduction

69

Cardiovascular disease is the number one cause of death globally and contributes a major

70

burden to public health systems worldwide (1). Several observational cohort studies have

71

found plant-based diets rich in vegetables to be associated with a lower incidence of

72

cardiovascular disease clinical endpoints (2-4). Specific vegetable groups, such as green leafy

73

vegetables, have been shown to be the most beneficial (5-9). There are many bioactive

74

components in green leafy vegetables that may benefit cardiovascular health. One component

75

that has gained research interest in the last decade is nitrate (10).

76

Nitrate is present in all vegetables at various concentrations; however, the richest sources of

77

nitrate are beetroot and green leafy vegetables (11). Increasing nitrate intake through the diet

78

is one potential strategy to increase nitric oxide (NO) bioavailability (12). NO plays an

79

important role in vascular tone and integrity, and is a vital molecule for cardiovascular health

80

(12). Reduced NO bioavailability has been observed in individuals with cardiovascular

81

disease (13). Strategies to increase NO in healthy individuals and those at risk of

82

cardiovascular disease may reduce cardiovascular-related events in the wider population.

83

Due to the increased research interest in the vascular benefits of dietary nitrate, the aim of

84

this review is to provide an overview of dietary nitrate as a source of NO, the importance of

85

the oral microbiome in the nitrate-nitrite-NO pathway, and dietary sources of nitrate. We have

86

also systematically compiled evidence to date on the effects of nitrate ingestion on blood

87

pressure, arterial stiffness, endothelial function, platelet function, and cerebral blood flow in

88

human and animal studies. This systematic literature search was conducted using criteria

89

outlined in the PRISMA checklist. Key search terms used in Medline and EMBASE

90

databases are outlined in Supplemental Table 1 and inclusion and exclusion criteria in

91

Supplemental Table 2. The PRISMA flow charts for human studies can be found in
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Supplemental Figure 1 and animal studies in Supplemental Figure 2. Articles were

93

excluded if full texts could not be accessed or the articles were not in English.

94

Two pathways to nitric oxide

95

Nitric oxide is an important cell signalling molecule critical for vascular homoeostasis (13). A

96

powerful vasodilator, NO relaxes smooth muscle tissue and increases regional blood flow

97

(14). Nitric oxide also inhibits platelet and leukocyte adhesion to the vessel wall, delaying the

98

onset of atherogenesis (15). Nitric oxide is generated through the L-arginine-NOS pathway

99

and the recently described enterosalivary nitrate-nitrite-NO pathway.

100

L-arginine-NOS pathway

101

Nitric oxide is synthesised predominantly through the classical L-arginine NO synthase

102

(NOS) pathway (16) which involves three types of NOS isoforms. These include neuronal

103

NOS (nNOS or NOS-1), cytokine-inducible NOS (iNOS or NOS-2), and endothelial NOS

104

(eNOS or NOS-3) (17). Due to the large mass of the endothelium within the body, eNOS is a

105

major contributor to NO production. The regulation of eNOS activity is via intracellular

106

calcium (Ca2+) (18) and several signal transduction pathways, including phosphoinoside 3-

107

kinase (PI3K) and adenylate cyclase (AC) pathways (19). An increase in shear stress, cyclic

108

strain or receptor activation of vascular endothelium by biochemical stimuli (bradykinin,

109

acetylcholine, thrombin, adenosine diphosphate, and serotonin) causes a release of Ca2+ from

110

intracellular stores, stimulating eNOS activity (17, 20). Phosphorylation of several residues

111

on the eNOS dimer is also an important requirement for activation (19). Equimolar amounts

112

of NO and L-citrulline are produced using L-arginine and molecular oxygen together with

113

tetrahydrobiopterin (BH 4 ) in a complex oxygen-dependent five electron-transfer reaction (18,

114

21).

115

Nitric oxide synthesised from L-arginine in the endothelium diffuses across the cell

116

membrane to nearby smooth muscle cells stimulating soluble guanylate cyclase (sGC) (18).
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This results in the synthesis of cyclic guanosine monophosphate (cGMP) from guanosine

118

triphosphate (GTP), triggering the relaxation of smooth muscle cells (18). Uncoupling of

119

eNOS, by reduced bioavailability of BH 4 or the substrate L-arginine, can lead to the

120

production of superoxide or H 2 O 2 (22). Furthermore, studies have demonstrated that reduced

121

tissue levels of BH 4 and increased superoxide generation are associated with risk factors for

122

atherosclerosis (23-25).

123

Nitrate-nitrite-NO pathway

124

Historically, nitrate and nitrite have been considered to be environmental pollutants and

125

potential carcinogenic residues in the food chain (26). Now, however, nitrate and nitrite are

126

considered important molecules for cardiovascular health (27).

127

Vegetables are a major source of nitrate consumed in the human population (28). When

128

nitrate is ingested, it is absorbed in the proximal area of the small intestine (12). Nitrate then

129

enters the bloodstream and mixes with endogenous sources of nitrate (mainly derived from

130

oxidation of NO through the L-arginine-NOS pathway). Approximately 75% of circulating

131

nitrate is excreted by the kidneys. The rest (~25%) is actively taken up by the salivary glands

132

where nitrate is concentrated in saliva and secreted in the oral cavity (29, 30). Nitrate is then

133

reduced to nitrite by facultative anaerobic bacteria found in the deep clefts on the dorsal

134

surface of the tongue (31). The commensal bacteria in the oral cavity use nitrate as an

135

alternative electron acceptor to oxygen during respiration, reducing nitrate to nitrite by nitrate

136

reductases (32). Once swallowed, a proportion of nitrite is rapidly protonated forming nitrous

137

acid (HNO 2 ) in the acidic environment of the stomach (33). Nitrous acid decomposes further

138

to form NO, having localised benefits (33). This non-enzymatic reduction of nitrite to NO is

139

enhanced by vitamin C and polyphenols (34, 35). The remaining nitrate and nitrite in the

140

stomach enter the small intestine and are absorbed into the bloodstream where they mix with
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endogenous forms of nitrate and nitrite (mainly derived from oxidation of NO through the L-

142

arginine-NOS pathway).

143

The one-electron reduction of nitrite to NO in the blood and tissues is catalysed by both

144

enzymatic and non-enzymatic pathways (10). Enzymatic pathways include a number of

145

proteins and enzymes including globins (such as haemoglobin, myoglobin, cytoglobin, and

146

neuroglobin), xanthine oxidoreductase, cytochrome P450, mitochondrial proteins, carbonic

147

anhydrase, aldehyde oxidase and eNOS (10). Non-enzymatic pathways include protons,

148

polyphenols, and vitamin C (10). Both enzymatic and non-enzymatic reductions of nitrite to

149

NO are enhanced during hypoxia and at a low pH (10, 36). Recent evidence suggests that the

150

acidic environment of the stomach plays an important role in the reduction of nitrite to NO

151

(37).

152

The nitrate-nitrite-NO pathway and the L-arginine-NOS pathway are interconnected through

153

the anions, nitrate and nitrite. Nitrate and nitrite are the oxidation end products of NO

154

metabolism through the L-arginine-NOS pathway but can also be derived from the diet (32).

155

Nitrate and nitrite, derived from the diet and derived as oxidation end products of NO

156

metabolism, are both recycled through the nitrate-nitrite-NO pathway. Both pathways become

157

a storage pool for NO production. Because the L-arginine-NOS pathway requires molecular

158

oxygen to produce NO, nitrite reduction to NO via the nitrate-nitrite-NO pathway may form

159

as a backup system for NO production during hypoxia. A crucial step in the nitrate-nitrite-NO

160

pathway is nitrate to nitrite reduction by the oral microbiome.

161

The oral microbiome

162

The oral microbiome is the second most diverse microbial community in the human body

163

comprising 50 – 100 billion bacteria, from over 700 prokaryotic taxa, as well as a fungal and

164

viral flora (38). Disturbances to the composition, and therefore function, of the oral

165

microbiome are thought to play a role in a number of diseases, including cardiovascular
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disease (38). Whether this link is related in part to the nitrate-nitrite-NO pathway is garnering

167

research interest. An important step in the nitrate-nitrite-NO pathway is the reduction of

168

nitrate to nitrite by facultative anaerobic bacteria found in the oral cavity. Reduced oral

169

bacterial nitrate to nitrite reduction, both in the presence and absence of dietary nitrate intake,

170

could have detrimental effects on the circulating NO pool with subsequent vascular effects. In

171

the presence of nitrate intake, interrupting the nitrate-nitrite-NO pathway with an antibacterial

172

mouthwash or spitting out of saliva, prevented the resultant increase in salivary and plasma

173

nitrite and the associated decrease in blood pressure (39, 40). In the absence of dietary nitrate

174

intake, increases in blood pressure with concomitant decreases in salivary and plasma nitrite

175

were observed with daily chlorhexidine based antibacterial mouthwash use in both healthy

176

volunteers (41) and treated hypertensives (42). This could be explained by the fact that nitrate

177

and nitrite, produced as end-products of NO metabolism, are recycled through the nitrate-

178

nitrite-NO pathway back into the circulating NO pool. Thus nitrate to nitrite reduction by the

179

oral microbiome could play a key role in blood pressure control. The influence on other

180

measures of vascular health has yet to be determined.

181

The fundamental role of the oral microbiome in the nitrate-nitrite-NO pathway and possibly

182

blood pressure control makes understanding all the factors that influence oral nitrate to nitrite

183

reduction an important research area. Indeed, there is evidence of a considerable variation

184

between individuals in the nitrate-reducing capacity of the oral microbiome (43). The first set

185

of factors to consider is the use of anti-bacterial mouthwashes, anti-bacterial toothpastes, and

186

antibiotics. Given the results of the studies described above, the widespread use of daily

187

mouthwash in the general population is of potential concern. The mouthwash used in these

188

studies, however, contained chlorhexidine, a strong antibacterial agent. Different effects have

189

been observed with other types and strengths of antibacterial mouthwashes (44). To date only

190

one study has examined the effect of antibacterial toothpaste, containing triclosan, on oral

10
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nitrate to nitrite reduction (45), with no effect observed. These results need to be confirmed in

192

additional studies examining the effect of mouthwash and toothpaste on oral nitrate

193

reduction. Interestingly, epidemiological studies show that regular tooth brushing and

194

mouthwash use, indicative of good oral hygiene, is associated with a decreased risk of

195

hypertension and cardiovascular disease (46, 47). The effect of antibiotic use on oral nitrate

196

to nitrite reduction has yet to be ascertained.

197

Other important factors are those inherent to the complex oral microbial community such as

198

bacterial genetics, the presence and influence of other microorganisms and environmental

199

pressures. There are a number of potential nitrate-reducing taxa present in the oral

200

microbiome. Doel et al (48) identified Veillonella spp as the most abundant nitrate-reducing

201

genus followed by Actinomyces, Rothia and Staphylococcus spp (48). Hyde et al (49)

202

confirmed Veillonella spp as the most abundant nitrate-reducing genus present but also

203

detected Prevotella, Neisseria and Haemophilus at a higher abundance than Actinomyces spp.

204

Nitrate to nitrite reduction by these bacteria is highly variable both within and between

205

bacterial species and needs to be examined in the context of the huge interdependent

206

microbial network in which they exist. This network comprises a heterogenous microbial

207

community within a biofilm which communicates using a process called quorum sensing.

208

These communities are highly complex, with all members influencing its health and vitality.

209

Interestingly, the presence of nitrite reducers may prevent the accumulation of nitrite in the

210

saliva and as such have a negative influence on the nitrate-nitrite-NO pathway (49).

211

Microbial nitrate metabolism can also be altered by environmental influences such as pH and

212

oxygen tension. A low pH in an oral microenvironment together with increased nitrate and

213

nitrite concentration, can select for nitrate-reducing bacteria (50). Nitrate-reducing bacteria

214

are facultative anaerobes. A low or no oxygen environment will therefore result in the nitrate

215

reductive pathway being utilised for respiration. Other potential factors influencing nitrate to
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nitrite reduction that requires future investigation include host factors such as age, diet, and

217

oral health.

218

The evidence of the link between oral health and cardiovascular disease being related to the

219

nitrate-nitrite-NO pathway is strongly suggestive. Future studies will need to examine this

220

relationship in the context of the large number of factors that could influence oral nitrate to

221

nitrite reduction.

222

Dietary sources of nitrate and nitrite

223

Vegetables contribute approximately 80% of dietary nitrate intake in the human population

224

(28, 51-54). Nitrate ingested in the diet can also be derived from other food sources such as

225

fruits, grains, and animal products with the remainder coming from drinking water. Many

226

countries have strict regulations to maintain low levels of nitrate in drinking water due to

227

underlying health concerns, such as methaemoglobinaemia (55). High levels, however, have

228

been detected in private wells in rural areas due to nitrogen-based fertiliser use in agricultural

229

areas (56). Another controversial health concern is the addition of nitrate and nitrite to meat

230

and their potential to form N-nitrosoamines, which are potential carcinogens (29).

231

Compounds such as polyphenols, vitamins C and E and other antioxidants inhibit the

232

formation of N-nitrosoamines (56). These compounds are abundant in vegetables. A large

233

number of countries have also set maximum levels for nitrate in vegetables, particularly for

234

lettuce and spinach, which are known to accumulate high amounts of nitrate (57). These

235

maximum levels vary across harvest period, being higher in winter and if grown under cover,

236

and lower in summer and if grown in open air (57).

237

Dietary nitrite, on the other hand, contributes only a small amount to human exposure and is

238

mainly consumed from animal-based foods such as cured meats and bacon (52). Nitrite is

239

added to these products as a preservative and to enhance taste and appearance (52). Although

240

a small amount of nitrite is consumed from these food sources, the majority of nitrite
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exposure (70-90%) is derived from the in vivo conversion of nitrate to nitrite through

242

endogenous pathways (58).

243

The nitrate content of vegetables depends on many different factors including the biological

244

properties of plants, fertiliser use, soil conditions, sun exposure, and cooking and storage

245

methods. The biological properties of plants can influence the amount of nitrate that

246

accumulates in that plant. For example, nitrate accumulates in different parts of the plants

247

with the leaf and stem having the highest concentrations, and the bulb and fruit having the

248

lowest (28). In our recently developed reference database for assessing dietary nitrate in

249

vegetables (11), leafy vegetables were found to have the highest nitrate content, with Chinese

250

flat cabbage and arugula containing the highest concentrations of nitrate (3000 mg/kg fresh

251

weight). Corn, mushroom, and peas had the lowest nitrate content (<50 mg/kg fresh weight).

252

Nitrate concentration in vegetables also differs between varieties. For example, Chinese

253

lettuce has a 3-fold higher nitrate value than iceberg lettuce (11).

254

Nitrogen-based fertilisers enhance the growth of plants, and thus, have an impact on how

255

much nitrate accumulates in vegetables. Nitrate located in the soil of a growing vegetable is

256

transported via the plant xylem system to the leaves of the vegetables (52). As organic

257

vegetables tend to be grown in fertilisers containing less nitrogen, by comparison

258

conventionally grown vegetables tend to accumulate higher nitrate levels (11, 59).

259

Other factors such as handling, storage, and processing, as well as temperature and light

260

intensity can also influence the amount of nitrate in vegetables (52). Higher nitrate levels are

261

observed in vegetables grown in winter compared to summer, and vegetables grown under

262

cover contain higher nitrate levels than those grown outdoors in the same season and the

263

same region (11, 52).

264

Storage in ambient temperature can also reduce the nitrate content of fresh vegetables. Under

265

refrigerated and frozen storage conditions nitrate levels appear to be unaffected (52).
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Endogenous nitrate reductase activity and the amount of bacterial contamination due to post-

267

harvest storage and wilting processes reduce nitrate and subsequently increase nitrite in fresh

268

vegetables (52). Being water soluble, nitrate is also reduced with washing and cooking

269

methods by approximately 10-15% and 50%, respectively (52). As nitrate is also found in the

270

skin of vegetables, peeling of the skin can also reduce nitrate levels by roughly 20-34% (52).

271

Nitrate ingestion and its effects on vascular function

272

Dietary nitrate is now considered an important alternative source of NO. Human and animal

273

studies to date have focused on the effects of nitrate ingestion on blood pressure, arterial

274

stiffness, endothelial function, platelet function, and cerebral blood flow, as discussed below.

275

A summary of the beneficial effects of nitrate ingestion on these cardiovascular-related

276

outcomes in human and animal studies is shown in Figure 1. Benefits of nitrate ingestion on

277

exercise performance will not be covered in this review.

278

Blood pressure

279

Evidence that decreased NO production was associated with hypertension raised the

280

possibility that nitrate, through the nitrate-nitrite-NO pathway, could partially account for the

281

blood pressure lowering effects of green leafy vegetables. Randomised controlled trials such

282

as the Dietary Approaches to Stop Hypertension (DASH) trial have been shown to reduce

283

blood pressure (60). It has been suggested that the high nitrate content of the DASH diet

284

contributes to the blood pressure lowering effects observed (28). The DASH diet has been

285

estimated to include as much as 1,222 mg (19.7 mmol) of nitrate per day (28). This amount

286

can, however, differ by as much as 700% due to the wide variation of nitrate in vegetables

287

(28). An Acceptable Daily Intake (ADI) of 3.7 mg nitrate per kg body weight was set by the

288

Joint Food and Agricultural Organisation and World Health Organisation (52). For an average

289

person weighing 70 kg, this is calculated to be 259 mg of nitrate. The DASH diet can provide

290

up to 500% more nitrate than this ADI.
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The DASH diet is associated with reductions of 4.5 mmHg in systolic blood pressure (SBP)

292

(61). This blood pressure reduction is similar to that seen in a meta-analysis demonstrating

293

that consumption of inorganic nitrate and nitrate-rich beetroot juice is associated with a SBP

294

reduction of 4.4 mmHg (62). There is now substantial evidence from human intervention

295

trials to demonstrate blood pressure reductions with short-term intake of dietary nitrate in

296

healthy populations (62). However, the effects of chronic nitrate intake on blood pressure in

297

older populations and populations at risk of cardiovascular disease remain uncertain (50, 63-

298

68).

299

Human studies

300

Our systematic literature search revealed 27 acute studies (≤24 hours) (Table 1) (40, 50, 63,

301

69-85) and 15 chronic studies (>1 day) (Table 2) (50, 65-68, 86-93) in 32 publications

302

investigating the effects of nitrate ingestion on blood pressure. Beetroot juice was the most

303

common nitrate source used in both acute and chronic studies. Twenty-four hour ambulatory

304

blood pressure (24-hour ABP), the preferred diagnostic method for assessing hypertension

305

(94, 95), was used in 10 studies (65-68, 77, 80-82, 87, 90). Clinic blood pressure was used in

306

34 studies (40, 50, 63, 65, 67, 69-76, 78, 79, 83-93) and four studies used home blood

307

pressure monitoring (66, 67, 87, 90).

308

Acute studies

309

The acute effects of nitrate ingestion on blood pressure were investigated between 2-24 hours

310

with nitrate doses ranging from 68-1488 mg (1.1-24 mmol) (Table 1). Five studies showed a

311

significant reduction in SBP only (78, 82-85) and four studies showed a significant reduction

312

in only diastolic blood pressure (DBP) (71, 77, 79, 80). Eleven studies showed significant

313

reductions in both SBP and DBP (40, 50, 71, 72, 81, 85). Acute reductions in SBP ranged

314

from 2.7 to 22.2 mmHg and 2.6 to 23.6 mmHg for DBP. Reductions in blood pressure were

315

seen across the entire range of nitrate doses investigated and in subjects that were healthy (40,

15
316

71, 72, 77, 78, 80-85), overweight (79), and hypercholesterolaemic (50). Sample sizes of

317

these populations ranged from 6 to 67 participants. Blood pressure reductions were not seen

318

in seven studies (63, 69, 70, 73-76). These populations consisted of subjects that were healthy

319

(69, 70, 73-76) and subjects with heart failure (63). Sample sizes of these populations ranged

320

from 5 to 40 participants.

321

Chronic studies

322

The chronic effects of nitrate ingestion on blood pressure were investigated in 15 studies

323

from 3 to 42 days (6 weeks) with nitrate doses ranging from 155-1104 mg/d (2.5-17.8

324

mmol/d) (Table 2). Three studies showed a significant reduction in SBP (88-90) and three

325

other studies showed a significant reduction in DBP (86, 92, 93). Only one study showed a

326

significant reduction in both SBP and DBP (87). In total, seven studies demonstrated a

327

significant reduction in blood pressure. It is worth noting, the study conducted by Ashworth

328

et al (88) was not clear whether the significant reductions in blood pressure were acute or

329

chronic as the subjects were advised to eat high nitrate vegetables 2-3 hours before blood

330

pressure was taken on the final day. Reductions in SBP ranged from 4.0 to 8.1 mmHg and

331

reduction in DBP ranged from 2.4 to 12 mmHg with nitrate doses ranging from 165-1104

332

mg/d (2.7-17.8 mmol/d). Reductions in blood pressure were seen in one study using 24-hour

333

ABP monitoring (87), two studies using home blood pressure (87, 90) and six studies using

334

clinic blood pressure (86-89, 92, 93). Blood pressure reductions were seen in subjects that

335

were healthy (86, 88, 92, 93), at moderate cardiovascular risk (89), older and overweight

336

(90), and grade 1 hypertensive (treated and untreated) (87). These studies were a mix of

337

young (mean age <37 y) (86, 88, 92, 93) and older cohorts (mean age >56 y) (87, 89, 90).

338

Most studies demonstrating reductions in blood pressure were of low sample size (n range 6-

339

25), except Kapil et al (87), which had a sample size of n=64.

16
340

Blood pressure reductions were not seen in eight studies (50, 65-68, 91). These populations

341

consisted of subjects that were older (91), pre-hypertensive (67), treated hypertensive (66),

342

overweight and obese (65), type 2 diabetic (68), and hypercholesterolemic (50). These

343

populations were all older adult populations (mean age >60 y) with larger sample sizes (n

344

range 27-67) (50, 65-68), apart from one study which had a sample size of n=8 (91).

345

There is now clear and convincing evidence that nitrate reduces blood pressure within hours

346

of ingestion. The evidence of chronic ingestion of nitrate on blood pressure is less clear.

347

Studies suggest that chronic intake of nitrate lowers blood pressure in young healthy

348

individuals; however, these blood pressure lowering effects are not seen in older individuals

349

and individuals at risk of cardiovascular disease. Recent evidence suggests possible

350

interactions between sulphate and nitrate which may explain some of these inconsistencies

351

(96). However, research is in need to further investigate this theory.

352

Animal studies

353

We identified 17 studies, in 12 publications, that assessed the effect of nitrate

354

supplementation on blood pressure in an animal model (Table 8). Nitrate sources included

355

NaNO 3 (n=10), KNO 3 (n=1), and Mg(NO 3 ) 2 (n=1) supplemented drinking water. Nitrate

356

doses ranged from 0.1-4.27 mmol/kg/d and treatment time ranged from 1 week to 12 months.

357

The number of animals in each treatment group ranged from 5 to 23. Nine studies reported a

358

decrease in blood pressure after nitrate supplementation and five studies reported no change

359

in blood pressure. Only one study reported an increase in blood pressure; Carlstrom et al

360

reported a significant increase in mean arterial pressure (MAP) in healthy rats after 8 weeks

361

of nitrate supplementation (1 mM/kg/d) (97). In the same study, a decrease in blood pressure

362

was seen with a 0.1 mM dose of nitrate. In two studies where high blood pressure was

363

induced, either by the use of spontaneously hypertensive rats (98, 99) or by administration of

364

a high-fructose diet (100), nitrate supplementation prevented the increase in blood pressure
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observed in the control group. In a study by Henzel et al, a decrease in MAP and SBP was

366

only seen in old (22 months) Sprague-Dawley rats and not in young (3 months) rats (101). It

367

is important to note that although both groups were receiving the same concentration of

368

nitrate in their drinking water, the younger rats were receiving a much higher dose of nitrate

369

(776 µmol/kg/d vs 290 µmol/kg/d), due to their higher water intake and lower body weight.

370

In a study by Khalifi et al, a decrease in SBP was only seen in diabetic Wistar rats and not

371

their healthy counterparts (102). This may be due to positive effects of nitrate

372

supplementation on NO status and oxidative stress, which would have been compromised in

373

the diabetic rats but not the healthy rats. Other studies have shown that higher doses of nitrate

374

can reduce blood pressure in animal models that have been shown to have reduced NO

375

bioavailability (100, 101, 103).

376

Endothelial function

377

The endothelium lines the entire vascular system and plays an essential role in the

378

maintenance of vascular homoeostasis (104). Dysfunction of the endothelium has been

379

identified in the development of atherosclerotic-related diseases (105). Flow-mediated

380

dilatation (FMD) via non-invasive ultrasound measures the endothelial function of the

381

brachial artery (106, 107). It is the gold standard method for assessing conduit artery

382

endothelial function (106) and is significantly associated with cardiovascular disease events

383

(108, 109). It has previously been shown from a meta-analysis of 14 prospective cohort

384

studies that the risk of experiencing a cardiovascular event is reduced by 13% for every 1%

385

higher in FMD (110). The degree of endothelial function is determined by the change in

386

brachial artery diameter before and after a shear stress stimulus, induced by reactive

387

hyperaemia (108). In the forearm vasculature, FMD provides a measure of endothelium-

388

derived NO bioavailability (111).

389

Human studies
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Our systematic literature search revealed seven acute studies (≤24 hours) (Table 3) (50, 75,

391

76, 79, 83, 84, 112) and four chronic studies (>1 day) (Table 4) (50, 68, 87, 89) in 10

392

publications investigating the effects of nitrate ingestion on FMD. Beetroot juice was the

393

most common nitrate source used in both acute and chronic studies.

394

Acute studies

395

The acute effects of nitrate ingestion on FMD were investigated between 1.5-4 hours with

396

nitrate doses ranging from 6-772 mg (0.1-12.4 mmol) (Table 3). The lower nitrate dose in this

397

range was estimated using the global average body weight of 62 kg as no average body

398

weight was reported in this study (75). Six studies demonstrated a significant improvement in

399

FMD (50, 75, 76, 79, 83, 112) and one study demonstrated no effect (84). Improvements in

400

FMD ranged from 0.5 to 4.0% were seen across the entire range of nitrate doses investigated.

401

Beetroot juice was also found to attenuate the postprandial impairment of FMD following a

402

high-fat meal (79). Improvements in FMD were seen in mainly healthy populations (75, 76,

403

83, 112). Other populations where improvements in FMD were seen included

404

hypercholesterolaemic (50) and overweight (79) subjects. These healthy and at risk

405

populations consisted of three studies in younger cohorts (mean age ≤27 y) (75, 76, 112) and

406

three studies in older cohorts (mean age >45 y) (50, 79, 83) with an overall sample size

407

ranging from 5 to 67. No effects on FMD were observed in one healthy population of 14

408

participants aged 28 y (84).

409

Chronic studies

410

The chronic effects of nitrate ingestion on FMD were investigated ranging from 14 to 42 days

411

(2 to 6 weeks) with nitrate doses ranging from 375 to 577 mg/d (6.0 to 9.3 mmol/d) (Table 4).

412

The higher nitrate dose in this range was estimated using the global average body weight of

413

62 kg as no average body weight was reported in this study (89). Three studies showed a

414

significant improvement in FMD (50, 87, 89) and one study had no effects (68). In particular,
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Rammos et al (89) demonstrated dietary nitrate reversed vascular dysfunction in older adults

416

with moderately increased cardiovascular risk. Improvements in FMD ranged from 0.5 to

417

1.1% and were seen across the entire range of nitrate doses investigated. Increases in FMD

418

(~1%) were seen in two studies (50, 87) using similar nitrate doses from beetroot juice (375

419

mg/d and 398 mg/d). Ingestion of a slightly higher nitrate dose of 577 mg/d (9.3 mmol/d)

420

using sodium nitrate showed a 0.5% improvement (89). Improvements in FMD were seen in

421

subjects with hypercholesterolemia (50), treated and untreated hypertension (87), and

422

moderate cardiovascular risk (89). All populations were older adult populations (mean age

423

>50 y) with large sample sizes (>60), except one study that had a sample size of 11 (89). No

424

effects on FMD were observed after 14 days of nitrate ingestion (beetroot juice) in 27

425

subjects with type 2 diabetes mellitus (68).

426

Animal studies

427

Numerous studies have reported that blood vessels with a damaged endothelium have

428

impaired vasorelaxation in response to acetylcholine (ACh) (Table 8) (113, 114). We

429

identified three animal studies, from two publications, investigating the effects of dietary

430

nitrate supplementation on endothelial function (97, 115). Bakker et al (115) demonstrated

431

that although supplementation with very high dose nitrate (10 mmol/kg/d) had no effect on

432

Ach-mediated vessel relaxation in a mouse model of atherosclerosis, low (0.1 mmol/kg/d)

433

and moderate (1 mmol/kg/d) dose nitrate supplementation significantly improved the

434

endothelial dysfunction associated with this mouse model. In addition, Carlstrom et al (97)

435

reported that dietary supplementation with a high dose of nitrate (1 mmol/kg/d) was

436

associated with attenuated acetylcholine-mediated vasorelaxation. These observations are in

437

support of the theory proposed by Carlstrom et al that there is cross-talk between the two

438

pathways of NO production. They suggest that high doses of dietary nitrate may inhibit

439

production of NO through the L-arginine-NOS pathway, leading to a net decrease in the
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440

amount of NO reaching the smooth muscle cells of the blood vessel (97). Although Bakker et

441

al showed improvements with a 1 mmol/kg/d dose of nitrate and Carlstrom et al reported no

442

improvements with the same dose, the animal model used is likely an important factor as the

443

Apolipoprotein-E knock-out mice used in the study by Bakker et al (115) have reduced NO

444

bioavailability.

445

Ischaemic reperfusion injury

446

Ischaemic reperfusion injury is tissue damage caused by a period of ischemia or lack of

447

oxygen. Lack of oxygen during an ischaemic period results in inflammation and oxidative

448

damage leading to microvascular dysfunction (116). Local and systemic tissue ischemia

449

remains the major cause of death from cardiovascular disease (1). As the nitrate-nitrite-NO

450

pathway is enhanced in times of hypoxia, this pathway may provide a back up to the classical

451

L-arginine-NO synthase pathway.

452

Human studies

453

Our systematic literature search revealed three acute studies (two publications) investigating

454

the effects of nitrate ingestion on ischaemic reperfusion injury (Table 5) (40, 85). Beetroot

455

juice was the most common nitrate source used. The acute effects of nitrate ingestion on

456

ischaemic reperfusion injury were investigated between 2-3 hours with nitrate doses ranging

457

from 341-1488 mg (5.5-24 mmol) (Table 5). Benefits were also seen in all studies where

458

beetroot juice (40, 85) and potassium nitrate (85) attenuated ischaemia reperfusion-induced

459

endothelial dysfunction measured using FMD. Improvements were seen in young (mean age

460

<28 y), healthy populations (40, 85) with an overall sample size ranging from 10 to 12.

461

Animal studies

462

We found only one study describing the effects of dietary nitrate supplementation on

463

ischaemia-induced revascularisation in an animal model (Table 8). In a study by Hendgen-

464

Cotta et al, mice were treated with either nitrate (1 g/L NaNO 3 in drinking water) or NaCl

21
465

(control) for 14 days (117). Perfusion recovery in the ischaemic hind limb was significantly

466

improved in mice treated with nitrate compared with controls via a significant increase in

467

capillary density. These results suggest that dietary nitrate supplementation may represent a

468

novel strategy to enhance ischaemia-induced revascularization.

469

Arterial stiffness

470

Pulse wave velocity (PWV) is a measure of aortic stiffness and is a strong predictor of

471

cardiovascular events (118-120). Pulse wave velocity is recognised as the most simple, non-

472

invasive, robust and reproducible technique to determine arterial stiffness and is considered

473

the gold-standard measurement of arterial stiffness (121). Pulse wave velocity measures

474

arterial stiffness by dividing the estimated distance between the carotid and femoral arteries

475

by the pulse transit time, the time delay between the carotid and femoral waveforms. A

476

tonometer is used to capture the carotid waveform and a cuff is placed around the femoral

477

artery to capture the femoral waveform. Augmentation index (AIx) is another measure of

478

arterial stiffness which provides a composite measure of elastic plus muscular artery stiffness

479

and wave reflection. Augmentation index has also been shown to be an independent predictor

480

of future cardiovascular disease events (122).

481

Human studies

482

Our systematic literature search revealed seven acute studies (≤24 hours) (50, 70, 72, 78-80,

483

84) and 5 chronic studies (>1 day) (50, 65, 67, 87, 89) in 10 publications investigating the

484

effects of nitrate consumption on arterial stiffness (Table 6). Beetroot juice was the most

485

common nitrate source used in both acute and chronic studies.

486

Acute studies

487

The acute effects of nitrate ingestion on arterial stiffness were investigated between 2-6 hours

488

with nitrate doses ranging from 68-583 mg (1.1-9.4 mmol) (Table 6). Three studies

489

demonstrated a significant decrease in arterial stiffness (50, 72, 84) and four studies

22
490

demonstrated no effect (70, 78-80). A significant decrease of 0.3 m/s in PWV was observed

491

in two studies (50, 84) with a nitrate dose of 375 mg (6 mmol) from beetroot juice (50) and

492

496 mg (8 mmol) from potassium nitrate (84). The study by Velmurugan et al (50) consisted

493

of a large sample size of 67 hypercholesterolaemic men and women with a mean age of 53 y,

494

whereas the study by Bahra et al (84) consisted of a smaller sample of 14 healthy individuals

495

with a mean age 28 y. Hughes et al (72) demonstrated a reduced AIx in young, but not old,

496

adults following a nitrate dose of 583 mg (9.4 mmol). No effect was seen in four studies with

497

nitrate doses ranging from 68-500 mg (1.1-8.1 mmol) using beetroot juice (70, 79), beetroot-

498

enriched bread (80), and spinach (78). These studies consisted of healthy (70, 78, 80) and

499

overweight (79) subjects.

500

Chronic studies

501

The chronic effects of nitrate ingestion on arterial stiffness were investigated from 7 to 42

502

days (1 to 6 weeks) with nitrate doses ranging from 300-600 mg/d (4.8-9.7 mmol/d) (Table

503

6). Three studies demonstrated a significant decreased in arterial stiffness after nitrate

504

ingestion (50, 87, 89) and two studies demonstrated no effect (65, 67). Studies found a

505

significant decrease of 0.2-1.2 m/s in PWV with nitrate doses ranging from 375-577 mg/d (6-

506

9.3 mmol/d) using beetroot juice and sodium nitrate (577 mg/d was estimated using the

507

global average body weight of 62 kg as no average body weight was reported in this study

508

(89)). The populations where an effect was observed had moderate cardiovascular risk (89),

509

untreated and treated hypertension (87), and hypercholesterolemia (50). No effect was seen in

510

two studies with nitrate doses of 300 mg/d (4.8 mmol/d) from green leafy vegetables (67) and

511

600 mg/d (9.7 mmol/d) from beetroot juice (65); populations that were overweight and obese

512

(65) and pre-hypertensive (67). It has been demonstrated that for every 3.4 m/s in increase in

513

PWV, the risk of experiencing a cardiovascular event is increased by 17% (118). Therefore, a
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decrease of 0.2-1.2 m/s in PWV is likely to provide a small but significant reduction in the

515

risk of experiencing a cardiovascular disease event.

516

Animal studies

517

Upon search of the literature, we found no animal studies investigating the effects of dietary

518

nitrate supplementation on arterial stiffness.

519

Platelet function

520

Platelets play a major role in the acute complications of atherosclerosis in the late stages of

521

the disease, which can subsequently lead to atherosclerotic-related events (123). Nitric oxide

522

has been shown to inhibit platelet aggregation and adhesion to the endothelial wall (124) and

523

there is now evidence to suggest dietary nitrate may repress platelet reactivity.

524

Human studies

525

Our systematic literature search identified five acute studies (≤24 hours) (40, 125, 126) and

526

one chronic study (>1 day) (50), in four publications, investigating the effects of nitrate

527

intake on platelet function (Table 7). Potassium nitrate was the most common nitrate source

528

used in acute studies whilst beetroot juice was used in the chronic study.

529

Acute studies

530

The acute effects of nitrate ingestion on platelet function were investigated between 2.5-3

531

hours with nitrate doses between 31-1054 mg (0.5-17 mmol) (Table 7). All five studies

532

demonstrated reductions in platelet aggregation and reactivity (40, 125, 126). Velmurugan et

533

al (125) demonstrated that nitrate ingestion decreased platelet reactivity in healthy males, but

534

not in healthy females. This was observed with both beetroot juice (192 mg or 3.1 mmol) and

535

potassium nitrate (496 mg or 8 mmol). Further studies using beetroot juice (1054 mg or 17

536

mmol) (40) and potassium nitrate (31 mg and 124 mg or 0.5 and 2 mmol) (126) demonstrated

537

reductions in platelet aggregation. All cohorts consisted of young healthy populations and
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were of small sample sizes (n<25). Further acute studies are needed to replicate these

539

findings in older adult populations at risk of developing cardiovascular disease.

540

Chronic studies

541

The chronic effects of nitrate ingestion on platelet function were investigated in only one

542

study (Table 7) (50). Velmurugan et al (50) demonstrated a reduction in platelet-monocyte

543

aggregates after 42 days of daily beetroot juice ingestion with a nitrate dose of 375 mg/d (6

544

mmol/d). This study had a large sample size (n=67) of older male and female adults aged 53

545

y with hypercholesterolemia. There is a strong need for further chronic studies to investigate

546

the effects of nitrate ingestion on platelet function in healthy populations and to replicate

547

findings in older adult populations at risk of cardiovascular disease.

548

Animal studies

549

Only one animal study has been published investigating the effects of dietary nitrate

550

supplementation on platelet function (Table 8). In this study, wild-type C57BL/6 mice were

551

supplemented with 1 g/L NaNO 3 in their drinking water for 1 week, placed on a low nitrate

552

diet or continued on standard mice chow (control) (127). Platelet aggregation was

553

significantly decreased in the group supplemented with nitrate and was significantly

554

increased in the group on the low nitrate diet, in comparison to the control group. These

555

findings demonstrate that manipulation of nitrate levels in blood, via supplementation or

556

dietary restriction, could affect platelet function in mice, although further studies are required

557

to corroborate this finding.

558

Cerebral blood flow

559

The effect of dietary nitrate on cerebral blood flow has been investigated in several studies

560

due to the observed effects of dietary nitrate on vasodilation and increases in blood flow.

561

Diminished blood flow to the brain is likely to contribute to the pathophysiological processes

562

underlying vascular cognitive impairment (128).
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Human studies

564

Our systematic literature search identified one acute study (≤24 hours) (129) and one chronic

565

study (>1 day) (130) in two publications investigating the effect of nitrate ingestion on

566

cerebral blood flow (Table 9). Sodium nitrate and a high nitrate diet were used as nitrate

567

sources.

568

Acute studies

569

Presley et al (129) demonstrated consuming a high nitrate diet (769 mg or 12.4 mmol of

570

nitrate) over a 24 hour period increased regional cerebral perfusion in frontal lobe white

571

matter, in older adults with a mean age of 75 y (Table 9). This was particularly evident in the

572

dorsolateral prefrontal cortex and anterior cingulate cortex. In the same study, however, the

573

acute effects of a high nitrate diet did not modify global cerebral perfusion.

574

Chronic studies

575

Aamand et al (130) demonstrated no effects after 3 days of sodium nitrate ingestion (477

576

mg/d or 7.7 mmol/d of nitrate, based on study mean weight of 77kg) on cerebral blood flow

577

in 20 healthy men (Table 9).

578

Animal studies

579

No animal studies investigating the effects of dietary nitrate supplementation on blood flow

580

were found.

581

Summary: nitrate ingestion and its effects on vascular function

582

Human intervention studies have now demonstrated ingestion of nitrate lowers blood

583

pressure and improves endothelial function. These studies are predominantly in healthy

584

populations and are of short duration. It is yet to be established whether nitrate ingestion has

585

the same effects in populations at higher risk of cardiovascular disease as few studies have

586

been conducted and findings are inconsistent. Further research is also needed to understand

587

the long-term effects of nitrate intake on cardiovascular clinical endpoints.
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Epidemiological evidence

589

Epidemiological studies have found plant-based diets rich in vegetables are associated with

590

lower rates of cardiovascular disease (2, 4, 131-136). In particular, cohort studies have shown

591

specific vegetable groups high in nitrate, such as green leafy vegetables, to be most beneficial

592

(6-9). The exact mechanisms for the protective effects shown in these studies are still

593

unknown. The Mediterranean diet (3, 137), the DASH diet (60, 138) and a vegetarian diet

594

(139, 140), all rich in vegetables, have been shown to be particularly beneficial towards

595

cardiovascular health. These diets are likely to contain substantially higher amounts of nitrate

596

than the average Western diet. Thus, nitrate is one possible candidate for explaining

597

cardiovascular health benefits seen with higher vegetable intakes (141).

598

There are very few observational epidemiological studies investigating nitrate intake and

599

cardiovascular-related health outcomes (Table 10). Although databases have been established

600

to calculate the nitrate intake in observational epidemiological studies (142-144), there was a

601

strong need for a more comprehensive database with compiled up-to-date data. Our recently

602

developed database on the nitrate content of vegetables (11) now gives researchers the

603

opportunity to conduct more observational epidemiological studies with an adequate

604

assessment of nitrate intake.

605

To date, there have been two articles published utilising the nitrate content of vegetables

606

database (11). We have demonstrated nitrate intake to be inversely associated with

607

atherosclerotic vascular disease mortality in a cohort of older adult women (mean age 75 ± 3

608

y) (53). In comparison to lower intakes of nitrate from vegetables <53 mg/d (median 39

609

mg/d), the inverse relationship with atherosclerotic vascular disease mortality plateaued at

610

intakes of 53-76 mg/d (median 63 mg/d) (53). In the same cohort of older adult women, we

611

also observed an inverse relationship between nitrate intake from vegetables and common

612

carotid artery intima-media thickness, as well as ischaemic cerebrovascular disease events
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(hospitalisation or death) (54). The inverse relationship with ischaemic cerebrovascular

614

disease events also plateaued at intakes of 53-76 mg/d (median 63 mg/d) (54).

615

Prior to these studies being published, the Tehran Lipid and Glucose Study reported on the

616

relationship between consumption of nitrate-containing vegetables and risk of hypertension

617

(145) and chronic kidney disease (CKD) (146), both risk factors for cardiovascular disease.

618

These studies investigated nitrate intake by assessing whole vegetables containing nitrate.

619

The authors further categorised nitrate-containing vegetables into low-nitrate, medium-nitrate

620

and high-nitrate vegetables. It is worth noting that these studies essentially investigated whole

621

vegetables and then different types of vegetables according to their nitrate levels and not

622

nitrate as a separate entity. It is, however, difficult to separate nitrate intake from vegetable

623

intake as the two can be highly correlated; as we have previously demonstrated (r=0.75,

624

P<0.001) (53). Golzarand et al (145) found a significant inverse association between the

625

intake of nitrate-containing vegetables and 3-year incidence of hypertension in the highest

626

tertile compared with the lowest tertile of nitrate-containing vegetables. There were no

627

significant associations observed between low-nitrate, medium-nitrate and high-nitrate

628

containing vegetables and 3-year risk of hypertension. As no associations were found

629

between categories of nitrate-containing vegetables, it is difficult to determine whether the

630

inverse association demonstrated with total nitrate-containing vegetables is due to vegetable

631

intake alone. This cohort consisted of 1,546 Iranian men and women (57% women), aged

632

38±12 years, without hypertension at baseline. In the same cohort, Mirmiran et al (146) found

633

that the highest compared to the lowest tertile of nitrate-containing vegetables was associated

634

with a lower estimated glomerular filtration rate and a higher prevalence of CKD at baseline.

635

This could be a demonstration of reverse causality bias where the diagnosis of chronic

636

disease has altered dietary intake. There was no association with the occurrence of CKD after

637

3 years of follow-up after excluding patients with CKD at baseline. Lastly, Bahadoran et al

28
638

(147) recently reported findings on the potential effects of dietary nitrate and nitrite on the

639

occurrence of type 2 diabetes in the same cohort of Iranian men and women (Tehran Lipid

640

and Glucose Study). Bahadoran et al (147) reported on 2,139 adults free of type 2 diabetes at

641

baseline with a median follow-up of 5.8 y. Nitrate and nitrite values were determined from a

642

recent survey conducted on frequently consumed food items among Iranians (148). Nitrate

643

and nitrite concentrations of 87 foods were determined using spectrophotometric methods.

644

The authors found no associations between nitrate intake and the risk of developing type 2

645

diabetes. However, the authors demonstrated an increased risk of type 2 diabetes among

646

participants with higher intakes of total and animal-based nitrite in the presence of low

647

vitamin C intake. The same was not observed in participants with high intakes of vitamin C

648

(>108 mg/d) (147), suggesting that diets high in vitamin C may counteract the suggested

649

adverse effects of nitrite on type 2 diabetes. However, higher intakes of total and animal-

650

based nitrite in the presence of low vitamin C intake may be a marker of an unhealthy diet

651

and lifestyle that may also be associated with a higher prevalence of type 2 diabetes.

652

There is a lingering concern that nitrate and nitrite may form cancerous compounds such as

653

nitrosamines (10). The majority of epidemiological studies to date have investigated

654

relationships between nitrate intake and cancer outcomes. A report compiled by the

655

International Agency for Research on Carcinogenicity concluded “Ingested nitrate or nitrite

656

under conditions that result in endogenous nitrosation is probably carcinogenic to humans

657

(Group 2A)” (149). Conditions that increase endogenous nitrosation are complex but could

658

involve interactions between the amount of nitrate and nitrite consumed, stomach acidity,

659

smoking status, medical conditions and the low intakes of nutrients that are likely to decrease

660

the potential for nitrosation such as polyphenols, vitamin C and vitamin E (56).

661

Now that there is a comprehensive database on the nitrate content of vegetables available,

662

researchers have the opportunity to further investigate the associations between chronic

29
663

intake of nitrate and health outcomes. Further research is needed to elucidate the relationships

664

amongst different populations including young vs. older age groups, low vs. higher

665

background nitrate intakes, and healthy vs. at risk populations.

666

Conclusion

667

There is now strong evidence to suggest that dietary nitrate derived from vegetables can

668

reduce blood pressure and other markers of vascular function in healthy populations. There is

669

a need for further research to investigate whether similar effects are observed in populations

670

at risk of developing cardiovascular disease. Few studies have investigated the long-term

671

effects of dietary nitrate on cardiovascular disease clinical endpoints; large observational

672

follow-up studies are required to address this. Further animal studies are required to elucidate

673

the mechanisms behind the observed beneficial effects. Increasing nitrate in the diet through

674

the consumption of nitrate-rich vegetables may prove to be an achievable and cost effective

675

way to reduce the risk of cardiovascular disease.
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Table 1. Intervention studies investigating the acute effects of inorganic nitrate on blood pressure in humans.
Blood
Nitrate source Nitrate dose Duration Subjects
pressure
effect
↓ Clinic SBP
Beetroot juice 583 mg
3h
Young: 25±4 y (10 M; 3 F)
Effect
↓ Clinic DBP
(9.4 mmol)
Old: 64±5 y (9 M; 3 F)
Healthy
↓ Clinic DBP
Sodium nitrate 800 mg
5h
28±1 y (11 M; 7 F)
(12.9 mmol)
Healthy
↓ Clinic SBP
Beetroot juice
↓ Clinic DBP
↓ Clinic SBP
Rocket salad
↓ Clinic DBP
beverage
↓ Clinic SBP
Spinach
↓ Clinic DBP
beverage
↓ Clinic SBP
Beetroot juice 375 mg
3h
Nitrate: 53±10 y (12 M; 21 F)
↓ Clinic DBP
(6 mmol)
Placebo: 53±12 y (12 M; 22 F)
Hypercholesterolaemic
↓ Clinic SBP
Spinach
220 mg
3.5 h
58.8±7.6 y (6 M; 20 F)
(3.5 mmol)
Healthy
↓ Clinic DBP
Beetroot juice 500 mg
2h
61±7 y(20 M)
(8.1 mmol)
Overweight
↓ Clinic SBP
Spinach
182 mg
3.3 h
47±14 y (6 M; 24 F)
(2.9 mmol)
Healthy
↓ Clinic SBP
Potassium
496 mg
3h
28±2 y (14)
nitrate
(8 mmol)
Healthy
↓ Clinic SBP
Potassium
1488 mg
24 h
23±1 y (8 M; 12 F)
↓ Clinic DBP
nitrate
(24 mmol)
Healthy

Screening/baseline Reference
blood pressure
Optimal/normal

Hughes
2016 (72)

Optimal/Normal

Jonvik 2016
(71)

Normal

Velmurugan
2016 (50)

Optimal

Liu 2013
(78)
Joris 2013
(79)
Bondonno
2012 (83)
Bahra 2012
(84)
Kapil 2010
(85)

High-normal
Optimal
Optimal
Optimal
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↓ Clinic SBP
↓ Clinic DBP

Potassium
nitrate

↓ Clinic SBP

Beetroot juice

↓ Clinic SBP
↓ Clinic DBP
↓ Ambulatory
DBP in T
carriers only
↓ Ambulatory
DBP
↓ Ambulatory
SBP
↓ Ambulatory
DBP
↓ Ambulatory
SBP
↓ Ambulatory
DBP
↓ Ambulatory
SBP
↓ Ambulatory
DBP
↓ Ambulatory
SBP
(M only)

Beetroot juice

248 mg, 744
mg
(4 mmol, 12
mmol)
341 mg
(5.5 mmol)
1395 mg
(22.5 mmol)
68 mg
(1.1 mmol)

3h

29±2 y (6)
Healthy

Optimal

3h

25±1 y (9)
Healthy
26 ± 5 y (9 M; 5 F)
Healthy
34±9 y (14 M)
Healthy

Normal

68 mg
(1.1 mmol)
0-707 mg
(0-11.4
mmol)

6h

31±2 y (23 M)
Healthy
31±3 y (18 M)
Healthy

Normal

White
beetrootenriched bread

99 mg
(1.6 mmol)

24 h

25±1 y (14 M)
Healthy

High-normal

Red beetrootenriched bread

112 mg
(1.8 mmol)

Beetroot juice

465 mg
(7.5 mmol)

24 h

43±3 y (15 M; 15 F)
Healthy

High-normal

Beetroot bread

Beetroot bread
Beetroot juice

24 h
6h

24 h

Optimal
Normal

High-normal

Webb 2008
(40)
Hobbs 2014
(77)
Hobbs 2013
(80)
Hobbs 2012
(81)

Coles and
Clifton
2012 (82)
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No effect

No effect on
clinic BP
No effect on
clinic BP

Beetroot gel

391 mg
(6.3 mmol)
341 mg
(5.5 mmol)

3h

No effect on
clinic BP

Sodium nitrate

0.1-10 mg/kg
body weight

4h

No effect on
clinic BP
No effect on
clinic BP
No effect on
clinic BP

Beetroot juice

694 mg
(11.2 mmol)
310 mg
(5 mmol)
738 mg
(11.9 mmol)

2h

No effect on
clinic BP

Beetroot juice

Beetroot juice

Beetroot juice
Beetroot juice

2.5 h

3h
3h

27±2 y (4 M; 1 F)
Healthy
Nitrate: 21±1 y (5 M; 15 F)
Placebo: 21±1 y (7 M; 13 F)
Healthy
25±1 y (15 M)
Healthy

Optimal

57±10 y (5 M; 4 F)
Heart failure
25±5 y (7 M; 4 F)
Healthy
Young: 27±6 y (11 M; 5 F)
Old: 59±6 y (8 M; 7 F)
Healthy
23±3 y (20 M)
Healthy

Optimal

Optimal

Optimal

Optimal
Normal/highnormal

da Silva
2016 (73)
Wightman
2015 (74)
RodriguezMateos
2015 (75)
Coggan
2015 (63)
Bakker
2015 (76)
Shepherd
2016 (69)

403-434 mg
2h
Optimal
Lefferts
(6.5-7.0
2016 (70)
mmol)
Screening/baseline blood pressure was based on criteria in the Australian guidelines for the diagnosis and management of hypertension in adults
(150). BP, blood pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure.

54

Table 2. Intervention studies investigating the chronic effects of inorganic nitrate on blood pressure in humans.
Blood
Nitrate source Nitrate dose Duration Subjects
Screening/baseline
pressure
blood pressure
effect
↓ Clinic DBP
Beetroot juice 450 mg/d
3d
24±1 y (6 M)
Normal
Effect
(7.3 mmol/d)
Healthy
↓ Clinic, home Beetroot juice 398 mg/d
28 d
n=64 (26 M; 38 F)
Grade 1
and
(6.4 mmol/d)
Nitrate: 58±14 y
hypertension
ambulatory
Placebo: 56±16 y
SBP
Drug-naïve and treated
↓ Clinic, home
hypertensive
and
ambulatory
DBP
↓ Clinic SBP
High nitrate
339±133
7d
20±2 y (19 F)
Optimal
vegetables
mg/d
Healthy
(5.5±2.1
mmol/d)
↓ Home SBP
Beetroot juice 300-400
21 d
n=21 (12 M; 9 F)
Normal/highmg/d
Beetroot:63±2 y
normal
No effect on
Placebo: 61±1 y
(4.8-6.4
clinic and
Older overweight
mmol/d)
ambulatory BP
↓ Clinic SBP

Sodium nitrate

9.3 mg/kg
body
weight/d

28 d

63±6 y (4 M; 7 F)
Moderate cardiovascular risk

High-normal

Reference

Keen 2015
(86)
Kapil 2015
(87)

Ashworth
2015 (88)

Jajja 2014
(90)

Rammos
2014 (89)
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↓ Clinic DBP

Japanese
traditional diet

18.8
mg/kg/body
weight/d

10 d

36±10 y (10 M; 15 F)
Healthy

Optimal

Sobko 2010
(92)

↓ Clinic DBP

Sodium nitrate

6.2 mg/kg
body
weight/d
375 mg/d
(6 mmol/d)

3d

24 y (15 M; 2 F)
Healthy

Optimal

Larsen 2006
(93)

42 d

Normal

Velmurugan
2016 (50)

Beetroot juice

600 mg/d
(9.7 mmol/d)

7d

Nitrate: 53±10 y (12 M; 21 F)
Placebo: 53±12 y (12 M; 22 F)
Hypercholesterolaemic
62±5 y (14 M; 16 F)
Overweight and obese

Normal/highnormal

Lara 2015
(65)

Beetroot juice

434 mg/d
(7 mmol/d)

7d

63±4 y (10 M; 17 F)
Treated hypertensive

High-normal

Bondonno
2015 (66)

Green leafy
vegetables

300 mg/d
(4.8 mmol/d)

7d

61±7 y (12 M; 26 F)
Pre-hypertensive

High-normal

Bondonno
2014 (67)

Beetroot juice

465 mg/d
(7.5 mmol/d)
155 mg/d
(2.5 mmol/d)
527 mg/d
(8.5 mmol/d)
682 mg/d
(11 mmol/d)

14 d

67±5 y (18 M; 9 F)
T2DM
73±5 y (3 M; 5 F)
Older

Grade 1
hypertension
High-normal

Gilchrist
2013 (68)
Miller 2012
(91)

No effect No effect on
clinic BP
No effect on
clinic and
ambulatory BP
No effect on
home and
ambulatory BP
No effect on
clinic, home
and
ambulatory BP
No effect on
ambulatory BP
No effect on
clinic BP

Beetroot juice

High nitrate
diet
Beetroot juice
Combination

3d
3d

Normal

3d

High-normal
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Screening/baseline blood pressure was based on criteria in the Australian guidelines for the diagnosis and management of hypertension in adults
(150). BP, blood pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure; T2DM, type 2 diabetes mellitus.
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Table 3. Intervention studies investigating the acute effects of inorganic nitrate on endothelial function in humans.
FMD effect
Nitrate source Nitrate dose
Duration
Subjects
↑ FMD
Beetroot juice
375 mg
3h
Nitrate: 53±10 y (12 M; 21 F)
Effect
(6 mmol)
Placebo: 53±12 y (12 M; 22 F)
Hypercholesterolaemic
↑ FMD
Beetroot juice
310 mg
3h
25±5 y (7 M; 4 F)
(5 mmol)
Healthy
↑ FMD
Sodium nitrate 0.1-10 mg/kg
4h
24±1 y (15 M)
body weight
Healthy
↑ FMD

Beetroot juice

↑ FMD

Sodium nitrate

↑ FMD

Spinach

No effect No effect

Potassium
nitrate
FMD, flow-mediated dilatation.

500 mg
(8.1 mmol)
9.3 mg/kg
body weight
182 mg
(2.9 mmol)
496 mg
(8 mmol)

2h
1.5 h
4h
3h

61±7 y (20 M)
Overweight
26±1 y (5 M; 5 F)
Healthy
47±14 y (6 M; 24 F)
Healthy
28±2 y (14)
Healthy

Reference
Velmurugan
2016 (50)
Bakker 2015
(76)
RodriguezMateos 2015
(75)
Joris 2013 (79)
Heiss 2012
(112)
Bondonno 2012
(83)
Bahra 2012 (84)
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Table 4. Intervention studies investigating the chronic effects of inorganic nitrate on endothelial function in humans.
FMD effect
Nitrate
Nitrate dose
Duration
Subjects
source
↑ FMD
Beetroot juice 375 mg/d
42 d
Nitrate: 53±10 y (12 M; 21 F)
Effect
(6 mmol/d)
Placebo: 53±12 y (12 M; 22 F)
Hypercholesterolaemic
↑ FMD
Beetroot juice 398 mg/d
28 d
n=64 (26 M; 38 F)
(6.4 mmol)
Nitrate: 58±14 y
Placebo: 56±16 y
Drug-naïve and treated hypertensive
↑ FMD
Sodium nitrate 9.3 mg/kg body 28 d
63±6 y (4 M; 7 F)
weight/d
Moderate cardiovascular risk
Beetroot juice 465 mg/d
14 d
67±5 y (18 M; 9 F)
No effect No effect
(7.5 mmol/d)
T2DM
FMD, flow-mediated dilatation; T2DM, type 2 diabetes mellitus.

Reference
Velmurugan
2016 (50)
Kapil 2015 (87)

Rammos 2014
(89)
Gilchrist 2013
(68)
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Table 5. Intervention studies investigating the acute effects of inorganic nitrate on ischemic reperfusion in humans.
Ischemic
Nitrate source Nitrate dose
Duration
Subjects
reperfusion
effect
Attenuated IRPotassium
1488 mg
3h
25±1 y (12)
Effect
induced
nitrate
(24 mmol)
Healthy
endothelial
dysfunction
Beetroot juice 341 mg
3h
(5.5 mmol)
Attenuated IRBeetroot juice 1395 mg
2h
27±7 y (4 M; 6 F)
induced
(22.5 mmol)
Healthy
endothelial
dysfunction
IR, ischemic reperfusion.

Reference

Kapil 2010 (85)

Webb 2008 (40)
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Table 6. Intervention studies investigating the effects of inorganic nitrate on arterial stiffness in humans.
Arterial
Nitrate source Nitrate dose
Duration
Subjects
stiffness effect
↓ AIx (young
Beetroot juice 583 mg
Acute (3 h)
Young: 25±4 y (10 M; 3 F)
Effect
only)
(9.4 mmol)
Old: 64±5 y (9 M; 3 F)
Healthy
↓ PWV
Potassium
496 mg
Acute (3 h)
28±2 y (14)
nitrate
(8 mmol)
Healthy
↓ PWV
Beetroot juice 375 mg/d
Acute (3 h)
Nitrate: 53±10 y (12 M; 21 F)
↓ AIx
(6 mmol)
Placebo: 53±12 y (12 M; 22 F)
Hypercholesterolaemic
↓ PWV
Chronic (42 d)
↓ PWV
Beetroot juice 398 mg/d
Chronic (28 d)
n=64 (26 M; 38 F)
↓ AIx
(6.4 mmol/d)
Nitrate: 58±14 y
Placebo: 56±16 y
Drug-naïve and treated hypertensive
↓ PWV
Sodium nitrate 9.3 mg/kg
Chronic (28 d)
63±6 y (4 M; 7 F)
↓ AIx
body weight/d
Moderate cardiovascular risk
Beetroot juice 403-434 mg
Acute (2 h)
23±3 y (20 M)
No effect No effect on
PWV and AIx
(6.5-7.0 mmol)
Healthy
No effect on
Beetroot bread 68 mg
Acute (6 h)
31±2 y (23 M)
PWV and AIx
(1.1 mmol)
Healthy
No effect on
Beetroot juice 500 mg
Acute (2 h)
61±7 y (20 M)
PWV and AIx
(8.1 mmol)
Overweight
No effect on
Spinach
220 mg
Acute (3.5 h)
59±8 y (6 M; 20 F)
PWV and AIx
(3.5 mmol)
Healthy
No effect on
Beetroot juice 600 mg/d
Chronic (7 d)
62±5 y (14 M; 16 F)
PWV
(9.7 mmol/d)
Overweight and obese

Reference
Hughes 2016
(72)
Bahra 2012 (84)
Velmurugan
2016 (50)

Kapil 2015 (87)

Rammos 2014
(89)
Lefferts 2016
(70)
Hobbs 2013 (80)
Joris 2013 (79)
Liu 2013 (78)
Lara 2015 (65)

61

No effect on
Green leafy
300 mg/d
PWV and AIx
vegetables
(4.8 mmol/d)
AIx, augmentation index; PWV, pulse wave velocity.

Chronic (7 d)

61±7 y (12 M; 26 F)
Pre-hypertensive

Bondonno 2014
(67)
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Table 7. Intervention studies investigating the effects of inorganic nitrate on platelet function in humans.
Platelet effect
Nitrate source Nitrate dose
Duration
Subjects
↓ in platelet
Beetroot juice 192 mg
Acute (3 h)
M: 26±1 y (12)
Effect
reactivity in
(3.1 mmol)
F: 24±2 y (12)
males but not
Healthy
females
↓ in platelet
Potassium
496 mg
Acute (3 h)
M: 27±1 y (12)
reactivity in
nitrate
(8 mmol)
F: 29±2 y (12)
males but not
Healthy
females
↓ in platelet
Beetroot juice 1054 mg
Acute (2.5 h)
31±2 y (5 M; 1 F)
aggregation
(17 mmol)
Healthy
↓ in platelet
Potassium
124 mg
Acute (2.5 h)
18-44 y (4 M; 3 F)
aggregation
nitrate
(2 mmol)
↓ in platelet
Potassium
31 mg, 124 mg Acute (2.5 h)
18-44 y (3 M; 3 F)
aggregation
nitrate
(0.5 mmol, 2
mmol)
↓ in plateletBeetroot juice 375 mg/d
Chronic (42 d)
Nitrate: 53±10 y (12 M; 21 F)
monocyte
(6 mmol/d)
Placebo: 53±12 y (12 M; 22 F)
aggregates
Hypercholesterolaemic

Reference
Velmurugan 2013
(125)

Webb 2008 (40)
Richardson 2002
(126)

Velmurugan 2016
(50)
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Table 8. Intervention studies investigating the effects of inorganic nitrate in animals.
Effect
Nitrate source
Background diet
Nitrate dose
↓ MAP (6.7
KNO 3 in
Not described
2.5 or 6.7
Blood
mmol dose only) drinking water
mmol/kg/d
pressure
No change in
MAP
↓ MAP
NaNO 3 in
Not described
0.1
drinking water
mmol/kg/d
↓ MAP (1mM
supplemented
High-salt diet
0.1 or 1
dose only)
with NaNO 3
mmol/kg/d
Prevented ↑ in
NaNO 3 in
Not described
1 mmol/kg/d
MAP
drinking water
No change in
MAP
↓ MAP
Supplemented
High-fructose diet 1.8
with NaNO 3
mmol/kg/d
Prevented ↑ in
MAP
↓ MAP
↓ MAP and ↓
DBP
No change in
MAP or SBP
↓ MAP and ↓
SBP

NaNO 3 in
drinking water

Standard chow

0.2
mmol/kg/d

Duration Animals
3w
Hypoxia WT male mice
(n≥8)
Hypoxia eNOS KO
male mice (n≥8)
8w
Rats (5≤n≥15)
8-11 w
8w

6w
10 w
from
start
1w
5d

NaNO 3 in
drinking water

Standard chow

0.8
mmol/kg/d
0.3
mmol/kg/d

2w

UNX Male Sprague–
Dawley rats
Male SH rats (n=6)
Normotensive Wistar
Kyoto rats (n=6)
Male Sprague–Dawley
rats (n=8)
Male Sprague–Dawley
rats (n=8)
Male Sprague-Dawley
rats (n=7)
Male Sprague-Dawley
rats
Young male Sprague–
Dawley rats (n=8)
Old male Sprague–
Dawley rats (n=5)

Reference
Baliga 2012
(151)

Carlstrom
2010 (152)
Carlstrom
2011 (103)
Chien 2014
(98)

Essawy
2014 (100)

Petersson
2009 (153)

Hezel 2016
(101)
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No change in
SBP
↓ SBP

NaNO 3 in
drinking water

No change in BP

NaNO 3 in
drinking water
Mg(NO 3 ) 2 in
drinking water
NaNO 3 in
drinking water

Smaller rise in
SBP
↓ MAP (0.1mM
dose only)
↑ MAP (1mM
dose only)
↓ Ach-mediated
Vascular
vasorelaxation
function
(1mM dose only)
No
vasorelaxation
↑ Ach-mediated
vessel relaxation
(0.1 and 1 mmol
dose only)
↑ Perfusion
Ischaemic
reperfusion recovery
Platelet
function

↓ collagen
induced platelet
aggregation

Standard chow

0.1 g/L

8w

Male Wistar rats (n=8)
Diabetic Male Wistar
rats (n=8)
LDL receptor KO mice
(n=15)
Male SH rats (n=7)

Western-type diet

0.2 mmol/d

14 w

Not described

0.3
mmol/kg/d
0.1 or 1
mmol/kg/d

4w

Standard chow

8-10 w

Male Sprague–Dawley
rats (n=5-12)

2-4 w

WT C57BL/6 mice
(n=5-12)

NaNO 3 in
drinking water

High-fat diet

0.1, 1 or 10
mmol/kg/d

10 w

NaNO 3 in
drinking water

Not described

5.0
mmol/kg/d

2w

NaNO 3 in
drinking water

Standard chow

1 g/L

1w

eNOS KO mice (n=512)
Male ApoE KO mice
(n= 8-12)

Male NMRI mice or
C57BL/6 mice (n=2123)
WT C57BL/6 mice
(n≥5)
eNOS KO mice (n≥5)

Khalifi
2015 (102)

Marsch
2016 (154)
Vilskersts
2014 (99)
Carlstrom
2015 (97)

Bakker
2016 (115)

HendgenCotta 2012
(117)
Park 2013
(127)
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Ach, acetylcholine; ApoE, apolipoprotein e; eNOS, endothelial nitric oxide synthase; KO, knock-out; LDL, low density lipoprotein; MAP,
mean arterial pressure; NMRI, Naval Medical Research Institute; NO, nitric oxide; NOS, nitric oxide synthase; SBP, systolic blood pressure;
SH, spontaneously hypertensive; UNX, uninephrectomized; WT, wild-type.
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Table 9. Intervention studies investigating the effects of inorganic nitrate on cerebral blood flow in humans.
Cerebral blood flow effect Nitrate source
Nitrate dose
Duration
Subjects
↑ regional cerebral
High nitrate diet
769 mg
Acute (24 h) 75±7 y (14)
Effect
perfusion in frontal lobe
(12.4 mmol)
Older
white matter but no effect
on global cerebral perfusion
6.2 mg/kg body Chronic (3 d) 25±1 y (20 M)
No effect No effect on cerebral blood Sodium nitrate
flow
weight/d
Healthy
NOS, nitric oxide synthase.

Reference
Presley 2011 (129)

Aamand 2014
(130)
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Table 10. Observational epidemiological studies of dietary nitrate and cardiovascular-related health outcomes
Study design and
Nitrate intake Primary
Adjusted variables
Results
population
assessment
outcome
15 y follow-up study
FFQ
ASVD mortality Model 1: Unadjusted.
↓ ASVD
n=1226
Model 2: Age and energy.
mortality
Australian female older adults
Model 3: Age, BMI, physical
Diabetes and ASVD-free
activity, alcohol intake, history of
75.1±2.7 y
smoking, socioeconomic status,
calcium supplementation group,
organic nitrate medication,
antihypertensive medication, statin
medication, low-dose aspirin, renal
function, and energy intake.
15 y follow-up study
FFQ
Ischaemic
Model 1: Unadjusted.
↓ ischaemic
n=1226
cerebrovascular Model 2: Age and energy.
cerebrovascular
Australian female older adults
disease
Model 3: Age, BMI, energy intake,
disease
Diabetes and ASVD-free
hospitalisation
alcohol intake, energy expended in
hospitalisation
75±3 y
and death
physical activity, antihypertensive
and death
medication, statin medication, lowdose aspirin medication, organic
nitrate medication, history of
smoking, and treatment.
Cross-sectional and 3 y
FFQ
eGFR and CKD Model 1: age, sex, and BMI.
↓ eGFR, ↑ CKD
follow-up study
Model 2: Additional adjustment for
(cross-sectional)
n=1538 cross-sectional
smoking, education, physical
n=1229 follow-up
activity, diabetes, and hypertension.
No association
Iranian male and female
for 3 year
adults (57% female)

Reference
Blekkenhorst
2017 (53)

Bondonno
2017 (54)

Mirmiran
2016 (146)
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38.0±12.0 y

5.8 y follow-up study
n=2139
Iranian male and female
adults (54.6% male)
T2DM-free
38.9±12.6 y
3 y follow-up study
Iranian male and female
adults (57% female)
38±12 y

FFQ

T2DM

FFQ

Hypertension

Model 3: Additional adjustment for
dietary intake of energy, fibre, and
potassium.
Model 1: Diabetes risk score.
Model 2: Additional adjustment for
dietary total fat, fibre, and vitamin C.

follow-up of
CKD
No association

Bahadoran
2017 (147)

Model 1: Adjusted for age and sex.
No association
Golzarand
Model 2: Additional adjustment for
2016 (145)
weight, 3-year weight change,
smoking, education, physical
activity, baseline SBP and DBP.
Model 3: Additional adjustment for
dietary intake of energy, fibre,
sodium, potassium and processed
meat.
ASVD, atherosclerotic vascular disease; BMI, body mass index; CKD, chronic kidney disease; DBP, diastolic blood pressure; eGFR,
estimated glomerular filtration rate; FFQ, food frequency questionnaire; SBP, systolic blood pressure; T2DM, type 2 diabetes mellitus.
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Figure legends:
Figure 1. Observed beneficial effects of nitrate ingestion on cardiovascular-related health
outcomes in human and animal studies. ASVD, atherosclerotic vascular disease; CVD,
cardiovascular disease.

